• 1
    Eddleston M., Rajapakse S., Rajakanthan, et al. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: A randomised controlled trial. Lancet 2000;355:967972.
  • 2
    Bayly WM. Acute renal failure. In: ReedSM, BaylyWM, eds. Equine Internal Medicine. Philadelphia , PA : WB Saunders; 1998: 848856.
  • 3
    Doering W., Konig E., Sturm W. Digitalis intoxication: Specificity and significance of cardiac and extracardiac symptoms. Part I: Patients with digitalis-induced arrhythmias. Z Kardiol 1977; 66: 121128.
  • 4
    Wijnberg ID, van der Kolk JH, Hiddink EG. Use of phenytoin to treat digitalis-induced cardiac arrhythmias in a miniature Shetland pony. Vet Rec 1999;144:259261.
  • 5
    Erichsen DF, Harris SG, Upson DW. Therapeutic and toxic plasma concentrations of digoxin in the cat. Am J Vet Res 1980;41:20492058.
  • 6
    Ochs HR, Greenblatt DJ, Harmatz JS, et al. Clinical implications of serum digoxin concentrations. Klin Wochenschr 1981;59:501507.
  • 7
    Galey FD, Holstege DM, Plumlee KH, et al. Diagnosis of oleander poisoning in livestock. J Vet Diagn Invest 1996;8:358364.
  • 8
    Reef VB. Pericardial and myocardial diseases. In: KoblickCN, ed. The Horse: Diseases and Clinical Management. New York , NY : Churchill Livingstone; 1993: 185197.
  • 9
    Reimer JM, Reef VB, Sweeney RW. Ventricular arrhythmias in horses: 21 cases. J Am Vet Med Assoc 1992;201:12371242.
  • 10
    Bonagura JD, Reef VB. Cardiovascular diseases. In: ReedSM, BaylyWM, eds. Equine Internal Medicine. Philadelphia , PA : WB Saunders; 1998: 290370.
  • 11
    Langford SD, Boor PJ. Oleander toxicity: An examination of human and animal exposures. Toxicology 1996;109:113.
  • 12
    Langer GA. Mechanisms of action of the cardiac glycosides on the heart. Biochem Pharmacol 1981;30:32613264.
  • 13
    Kingsbury JM. Poisonous plants of the United States and Canada. Englewood Cliffs , NJ : Prentice-Hall; 1964: 264267.
  • 14
    Holstege DM, Francis T., Puschner B., et al. Multiresidue screen for cardiotoxins by two-dimensional thin-layer chromatography. J Agric Food Chem 2000;48:6064.
  • 15
    Datta P., Dasgupta A. Interference of oleandrin and oleandri-genin in digitoxin immunoassays: Minimal cross reactivity with a new monoclonal chemiluminescent assay and high cross reactivity with the fluorescence polarization assay. Ther Drug Monit 1997;19:465469.
  • 16
    Dasgupta A., Emerson L. Neutralization of cardiac toxins ole-andrin, oleandrigenin, bufalin, and cinobufatalin by digibind: Monitoring the effect by measuring free digitoxin concentrations. Life Sci 1998;63:781788.
  • 17
    Teske RH, Bishop SP, Righter HF, et al. Subacute digoxin toxicosis in the beagle dog. Toxicol Appl Pharmacol 1976;35:283301.
  • 18
    Plumb DC. Veterinary Drug Handbook, 2nd ed. Ames , IA : Iowa State University Press; 1995: 221223.
  • 19
    Marr CM. Treatment of cardiac arrhythmias and cardiac failure. In: RobinsonNE, ed. Current Therapy in Equine Medicine 4. Philadelphia , PA : WB Saunders; 1997: 250255.
  • 20
    Vukmir RB, Stein KL. Torsades de pointes therapy with phe-nytoin. Ann Emerg Med 1991;20:198200.